Frequency of Female Athlete Triad Among Elite Female Athlete of Iran in Different Sport in 2007
This study has been terminated.
(the study terminated last week)
Sponsor:
Tehran University of Medical Sciences
Information provided by:
Tehran University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01183377
First received: August 13, 2010
Last updated: August 16, 2010
Last verified: August 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Women's evermore presence in professional and athletic sports has revealed sound evidence on the existence of female athlete triad among the world's elite female athletes. This triad consists of eating disorders, amenorrhea and osteoporosis. It has been stated that all female athletes are potentially at risk, but it is not clear to what extent those exercising at different levels are at risk of this syndrome/triad. Since the manifestation of this triad is often denied, or under-reported, appropriate screening methods are required to identify the symptoms. There is still no clear-cut information available on the incidence of this triad in Iran. And there are religious and cultural differences between Iran's elite female athletes and those in other countries. Therefore, in order to meet Iranian female athletes' needs, the investigators decided to determine the frequency of the female athlete triad in Iran.
| Condition |
|---|
|
Menstruation Disturbances Eating Disorder Bone Loss |
| Study Type: | Observational |
| Study Design: | Time Perspective: Cross-Sectional |
| Official Title: | Screening of Menstrual Disorder in Elite Feamle Athlete in Iran |
Resource links provided by NLM:
Further study details as provided by Tehran University of Medical Sciences:
Primary Outcome Measures:
- Prevalence of Female Athlete Triad among Elite female athlete in Iran in 2006 [ Time Frame: 24 month ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- prevalence of menstrual disorder in female athlete in Iran in 2006 [ Time Frame: 24 month ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 250 |
| Study Start Date: | October 2006 |
| Estimated Study Completion Date: | March 2009 |
| Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Female athlete Triad syndrom was based on menstrual disorder,Eating Disorder and bone loss
|
Eligibility| Ages Eligible for Study: | 13 Years to 45 Years (Child, Adult) |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Study population: Professional Iranian female athletes who are members in national teams or federations sports and champion team in Tehran
Criteria
Inclusion Criteria:
- All Elite Female athletes who play in international teams in sport federation or champion Team in Tehran between 13-45 years old.
Exclusion Criteria:
- The 13-15 year old female athletes who are not manarch with secondary sex charactristics.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01183377
Please refer to this study by its ClinicalTrials.gov identifier: NCT01183377
Locations
| Iran, Islamic Republic of | |
| Rheumatology Research Center, Shariati Hospital | |
| Tehran, Iran, Islamic Republic of, 14114 | |
Sponsors and Collaborators
Tehran University of Medical Sciences
Investigators
| Study Director: | Haleh Dadgostar, MD | Rheumatology Research Center, Tehran University for Medical Sciences |
| Principal Investigator: | Fereydoun Davatchi, MD | Rheumatology Research Center, Tehran University for Medical Sciences |
| Principal Investigator: | Shafie Movaseghi, MD | Rheumatology Research Center, Tehran University for Medical Sciences |
| Principal Investigator: | ashraf Aleyasin, MD | Tehran University for Medical Sciences |
| Principal Investigator: | mohamad hosein Forozanfar, MD | Rheumatology Research Center, Tehran University for Medical Sciences |
| Principal Investigator: | Talia Alenabi, MD | Sport Medicine Federation of Islamic Republic Of Iran |
| Principal Investigator: | Narges Chime, MD | Shahid Beheshti University of Medical Sciences |
| Principal Investigator: | pooneh Kimia ghalam, MD | Health ministry of Iran |
More Information
| Responsible Party: | Rheumatology Research Center, Haleh Dadgostar |
| ClinicalTrials.gov Identifier: | NCT01183377 History of Changes |
| Other Study ID Numbers: | 85-01-41-3488 |
| Study First Received: | August 13, 2010 |
| Last Updated: | August 16, 2010 |
| Health Authority: | Iran: Ethics Committee |
Keywords provided by Tehran University of Medical Sciences:
|
Female Athlete Triad syndrom Eating disorder osteoprosis |
Additional relevant MeSH terms:
|
Feeding and Eating Disorders Menstruation Disturbances Female Athlete Triad Syndrome Mental Disorders Pathologic Processes Osteoporosis |
Bone Diseases, Metabolic Bone Diseases Musculoskeletal Diseases Gonadal Disorders Endocrine System Diseases |
ClinicalTrials.gov processed this record on September 23, 2016